ALKBH7 and glioblastoma: These results further highlighted the ALKBH7/APNG axis contributing to TMZ resistance and provided new evidence that targeting on ALKBH7 might be a potential adjuvant strategy in inhibiting TMZ resistance against glioblastoma (Figure 8).